tirzepatide update Mission Family Medicine launches in-clinic program Oral tirzepatide for flexible weight-loss

RETATRUTIDE An experimental medication developed by Eli Lilly that is being studied as a next generation treatment for obesity, overwight symptoms and many other related metabolic conditions such as type 2 diabetes

The way patients were chosen, the drugs they were given, and the timelines applied all stacked the odds against GLP1 therapy

For example, patients with signs of AUD who do not consider themselves alcoholics may be willing to accept GLP-1 treatment because of the lack of stigma surrounding the drug and the other medical reasons they will be able to tell loved ones about why they are taking the medication

At Calla Genics, our clinicians don't just focus on making you slimmer

Convenience: Centrally located in Alpharetta, making advanced therapies accessible to North Georgia communities